Credit Suisse Ag Icad Inc Transaction History

Credit Suisse Ag

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$3.02 - $4.56 $36 - $54	12 New	12 $0
Q3 2021 Nov 12, 2021	SELL	$10.11 - $17.56 $518,885 - $901,249	-51,324 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$14.9 - $20.82 $764,727 - $1.07 Million	51,324 New	51,324 $889,000
Q2 2020 Aug 12, 2020	SELL	$6.63 - $12.85 $90,075 - $174,580	-13,586 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$6.94 - $14.42 $376,543 - $782,385	-54,257 Reduced 79.97%	13,586 $100,000
Q4 2019 Feb 12, 2020	BUY	$6.23 - $7.98 $422,661 - $541,387	67,843 New	67,843 $527,000

5.45M

3.6K

14.6K

Ticker ICAD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 25,333,900
Market Cap $42.6M
Description
iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.